Dynavax to Present at the Wedbush 2011 Life Sciences Conference
(firmenpresse) - BERKELEY, CA -- (Marketwire) -- 08/11/11 -- Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it plans to present at the Wedbush 2011 Life Sciences Conference in New York on Wednesday, August 17, 2011 at 10:00 am EDT (1:00 pm PDT).
Brant Biehn, Chief Commercial Officer of Dynavax, and Shari Annes, Investor Relations of Dynavax, will provide a corporate overview presentation. To access the live webcast and the subsequent archived recording of the presentation, please log onto Dynavax's website at .
Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. The Company's lead product candidate is HEPLISAV™, a Phase 3 investigational adult hepatitis B vaccine designed to provide rapid and superior protection with fewer doses than current licensed vaccines. For more information visit .
Shari Annes
Investor Relations
510-665-7211
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 11.08.2011 - 07:00 Uhr
Sprache: Deutsch
News-ID 1029783
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
BERKELEY, CA
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 120 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Dynavax to Present at the Wedbush 2011 Life Sciences Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von
Dynavax Technologies (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
